Services
Trademarks
Protect your brand today
Register your Trademark
Post Filing Services
Trademark Protection
Patents
File a patent today
Start a Patent Application
Copyrights
Safeguard your creative ideas
Start a Copyright Application
Business
Incorporate your business today
Start a Business
Legal Forms for Business
Resources
Guest
Trademark Search
ENTRADA THERAPEUTICS
REGISTERED
on 27 Sep 2023
Last Applicant/ Owned by
ENTRADA THERAPEUTICS INC.
6 Tide StreetBoston MA 02210
US
Serial Number
2088866 filed on 05th Nov 2020
Registration Number
TMA1200009 registered on 27th Sep 2023
Registration expiry Date
05th Nov 2030Correspondent Address
130 Queens Quay EastEast Tower, Suite 809Toronto,
ONTARIO
CA
M5A0P6
ENTRADA THERAPEUTICS
Vienna Information
25 . 7 . 20
Surfaces or backgrounds covered with lines or bandsSurfaces ou fonds couverts de lignes ou de bandes
26 . 11 . 3
More than two lines or two bandsPlus de deux lignes ou de deux bandes
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
Trademark usage description
pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, arthritis, rheumatoid arthritis, osteoarthritis, inflamm Read MoreClassification Information
Class [005]
Pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, arthritis, rheumatoid arthritis, osteoarthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis, inflammatory muscle diseases and disorders, Chronic inflammatory demyelinating polyneuropathy, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of genetic diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, Abarognosis, Acquired Epileptiform Aphasia, Acute disseminated encephalomyelitis, Adrenoleukodystrophy, Agenesis of the corpus callosum, Agnosia, Aicardi syndrome, Alexander disease, Alien hand syndrome, Allochiria, Alpers' disease, Alternating hemiplegia, Alzheimer's disease, Amyotrophic lateral sclerosis, Anencephaly, Angelman syndrome, Angiomatosis, Anoxia, anxiety disorders, Aphasia, Apraxia, Arachnoid cysts, Arachnoiditis, Arnold- Chiari malformation, Arteriovenous malformation, Ataxia Telangiectasia, Attention deficit hyperactivity disorder, Auditory processing disorder, Autonomic Dysfunction, Back Pain, Batten disease, Behcet's disease, Bell's palsy, Benign Essential Blepharospasm, Benign Intracranial Hypertension, Bilateral frontoparietal polymicrogyria, Binswanger's disease, Blepharospasm, Bloch-Sulzberger syndrome, Brachial plexus injury, Brain abscess, Brain damage, brain diseases, Brain injury, Brown-Séquard syndrome, Canavan disease, Carpal tunnel syndrome, Causalgia, central nervous system infections, central nervous system movement disorders, Central pain syndrome, Central pontine myelinolysis, Centronuclear myopathy, Cephalic disorder, Cerebral aneurysm, Cerebral arteriosclerosis, Cerebral atrophy, Cerebral gigantism, Cerebral palsy, Cerebral vasculitis, Cervical spinal stenosis, Charcot-Marie-Tooth disease, Chiari malformation, Chorea, Chronic fatigue syndrome, Chronic inflammatory demyelinating polyneuropathy (CIDP), Inflammatory demyelinating polyneuopathy, Idiopathic Inflammatory Demyelinating Diseases, Progressive inflammatory neuropathy, Chronic pain, Coffin Lowry syndrome, cognitive disorders, Coma, Complex regional pain syndrome, Compression neuropathy, Congenital facial diplegia, Corticobasal degeneration, Cranial arteritis, Craniosynostosis, Creutzfeldt-Jakob disease, Cumulative trauma disorders, Cushing's syndrome, Cytomegalic inclusion body disease (CIBD), Cytomegalovirus Infection, Dandy-Walker syndrome, Dawson disease, De Morsier's syndrome, Dejerine- Klumpke palsy, Dejerine-Sottas disease, Delayed sleep phase syndrome, Dementia, depression, Dermatomyositis, Developmental dyspraxia, Diabetic neuropathy, Diffuse sclerosis, Dravet syndrome, Dysautonomia, Dyscalculia, Dysgraphia, Dyslexia, Dystonia, Empty sella syndrome, Encephalitis, Encephalocele, Encephalotrigeminal angiomatosis, Encopresis, Epilepsy, Erb's palsy, Erythromelalgia, Essential tremor, Fabry's disease, Fahr's syndrome, Fainting, Familial spastic paralysis, Febrile seizures, Fisher syndrome, Friedreich's ataxia, Fibromyalgia, Gaucher's disease, Gerstmann's syndrome, Giant cell arteritis, Giant cell inclusion disease, Globoid Cell Leukodystrophy, Gray matter heterotopia, Guillain-Barré syndrome, HTLV-1 associated myelopathy, Hallervorden-Spatz disease, Head injury, Headache, Hemifacial Spasm, Hereditary Spastic Paraplegia, Heredopathia atactica polyneuritiformis, Herpes zoster oticus, Herpes zoster, Hirayama syndrome, Holoprosencephaly, Huntington's disease, Hydranencephaly, Hydrocephalus, Hypercortisolism, Hypoxia, Immune-Mediated encephalomyelitis, Inclusion body myositis, Incontinentia pigmenti, Infantile phytanic acid storage disease, Infantile Refsum disease, Infantile spasms, Inflammatory myopathy, inflammatory-related pain, insomnia, Intracranial cyst, Intracranial hypertension, Joubert syndrome, Karak syndrome, Kearns-Sayre syndrome, Kennedy disease, Kinsbourne syndrome, Klippel Feil syndrome, Krabbe disease, Kugelberg-Welander disease, Kuru, Lafora disease, Lambert-Eaton myasthenic syndrome, Landau-Kleffner syndrome, Lateral medullary (Wallenberg) syndrome, Learning disabilities, namely dyslexia, dysgraphia, dyscalculia and auditory processing disorder, and Leigh's disease, Lennox- Gastaut syndrome, Lesch-Nyhan syndrome, Leukodystrophy, Lewy body dementia, Lissencephaly, Locked-In syndrome, Lou Gehrig's disease, Lumbar disc disease, Lumbar spinal stenosis, Lyme disease-Neurological Sequelae, Machado-Joseph disease (Spinocerebellar ataxia type 3), Macrencephaly, Macropsia, Megalencephaly, Melkersson-Rosenthal syndrome, Menieres disease, Meningitis, Menkes disease, Metachromatic leukodystrophy, Microcephaly, Micropsia, Migraine, Miller Fisher syndrome, Mini-stroke (transient ischemic attack), Mitochondrial myopathy, Mobius syndrome, Monomelic amyotrophy, mood disorders, Motor Neurone Disease, Motor skills disorder, Moyamoya disease, Mucopolysaccharidoses, Multiinfarct dementia, Multifocal motor neuropathy, Multiple system atrophy, Muscular dystrophy, Duchenne muscular dystrophy, Myalgic encephalomyelitis, Myasthenia gravis, Myelinoclastic diffuse sclerosis, Myoclonic Encephalopathy of infants, Myoclonus, Myopathy, Myotubular myopathy, Myotonia congenital, Narcolepsy, Neurofibromatosis, Neurolep tic malignant syndrome, Neurological manifestations of AIDS, Neurological sequelae of lupus, Neuromyotonia, Neuronal ceroid lipofuscinosis, Neuronal migration disorders, neuropathic pain, Niemann-Pick disease, Non 24-hour sleep-wake syndrome, Nonverbal learning disorder, O'Sullivan- McLeod syndrome, Occipital Neuralgia, Occult Spinal Dysraphism Sequence, ocular motility disorders, Ohtahara syndrome, Olivopontocerebellar atrophy, Opsoclonus myoclonus syndrome, Optic neuritis, Orthostatic Hypotension, Overuse syndrome, Palinopsia, Paresthesia, Parkinson's disease, Paramyotonia Congenita, Paraneoplastic diseases, Paroxysmal attacks, Parry-Romberg syndrome, Pelizaeus-Merzbacher disease, Periodic Paralyses, Peripheral neuropathy, Persistent Vegetative State, Pervasive developmental disorders, Photic sneeze reflex, Phytanic acid storage disease, Pick's disease, Pinched nerve, Polymicrogyria (PMG), Polio, Polymicrogyria, Polymyositis, Porencephaly, Post-Polio syndrome, Postherpetic Neuralgia (PHN), Postinfectious Encephalomyelitis, Postural Hypotension, Prader-Willi syndrome, Primary Lateral Sclerosis, Prion diseases, Progressive hemifacial atrophy, Progressive multifocal leukoencephalopathy, Progressive Supranuclear Palsy, Pseudotumor cerebri, psychoses, Rabies, Ramsay-Hunt syndrome (Type I and Type II), Rasmussen's encephalitis, Reflex neurovascular dystrophy, Refsum disease, Repetitive motion disorders, Repetitive stress injury, Restless legs syndrome, Retrovirus-associated myelopathy, Rett syndrome, Reye's syndrome, Rhythmic Movement Disorder, Romberg syndrome, Saint Vitus dance, Sandhoff disease, Schizophrenia, Schilder's disease, Schizencephaly, seizure disorders, Sensory integration dysfunction, Septooptic dysplasia, Shaken baby syndrome, Shingles, Shy-Drager syndrome, Sjögren's syndrome, Sleep apnea, Sleeping sickness, Snatiation, Sotos syndrome, Spasticity, Spina bifida, spinal cord diseases, Spinal cord injury, Spinal muscular atrophy, Spinocerebellar ataxia, Steele-Richardson-Olszewski syndrome, Stiff-person syndrome, Stroke, Sturge-Weber syndrome, Subacute sclerosing panencephalitis, Subcortical arteriosclerotic encephalopathy, Superficial siderosis, Sydenham's chorea, Syncope, Synesthesia, Syringomyelia, Tarsal tunnel syndrome, Tardive dyskinesia, Tarlov cyst, Tay-Sachs disease, Temporal arteritis, Tetanus, Tethered spinal cord syndrome, Thomsen disease, Thoracic outlet syndrome, Tic Douloureux, Todd's paralysis, Tourette syndrome, Toxic encephalopathy, Transient ischemic attack, Transmissible spongiform encephalopathies, Transverse myelitis, Traumatic brain injury, Tremor, Trigeminal neuralgia, Tropical spastic paraparesis, Trypanosomiasis, Tuberous sclerosis, Von Hippel-Lindau disease, Viliuisk Encephalomyelitis, Wallenberg's syndrome, Werdnig-Hoffman disease, West syndrome, Whiplash, Williams syndrome, Wilson's disease, and Zellweger syndrome, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, metabolic syndrome, hypoglycaemia, gout, anemia, bulimia nervosa, anorexia, obesity, weight loss and weight management, Pompe disease, hepatitis, non alcoholic fatty liver disease (NAFLD), non alcoholic steatohepatitis (NASH), liver fibroids, cirrhosis, and hypothyroidism, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of infectious diseases, namely, bacterial infections, viral infections, fungal infections, parasitic infections, protozoal infections, preon infections, and worm infections, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of hematological diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of musculo-skeletal diseases and disorders, namely, connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, gout, fractures, sprains, sports injuries, osteogenesis imperfecta, muscle wasting (cachexia), renal osteodystrophy, muscular dystrophy, Duchenne muscular dystrophy, Becker muscular dystrophy, Facioscapulohumeral Muscular Dystrophy (FSHD), Merosin-deficient congenital muscular dystrophy type 1A (MDC1A), proximal spinal muscular atrophy (SMA), myotonic dystrophy, oculopharyngeal muscular dystrophy (OPMD), myotonic dystrophy type 1, myotonic dystrophy type 2, cartilage injuries, joint replacement, osteoarthritis, neuromuscular disorders, Pompe disease, -thalassemia, dystrophin Kobe, diabetes, Alzheimer's disease, cystic fibrosis, Merosin-deficient congenital muscular dystrophy type 1A (MDC1A), proximal spinal muscular atrophy (SMA), Huntington's disease, Huntington disease-like 2 (HDL2), myotonic dystrophy, spinocerebellar ataxia, spinal and bulbar muscular atrophy (SBMA), dentatorubral-pallidoluysian atrophy (DRPLA), frontotemporal dementia, Fragile X syndrome, fragile X mental retardation 1 (FMR1), fragile X mental retardation 2 (FMR2), Fragile XE mental retardation (FRAXE), Friedreich's ataxia (FRDA), obesity, fragile Xassociated tremor/ataxia syndrome (FXTAS), myoclonic epilepsy, oculopharyngeal muscular dystrophy (OPMD), syndromic X-linked mental retardation, non-syndromic X-linked mental retardation, myotonic dystrophy, myotonic dystrophy type 1, myotonic dystrophy type 2, epilepsy, Dravet syndrome, lysosomal storage disease, Parkinson's Disease, autism, heart disease, arthritis, yellow fever, sickle cell disease, cardiovascular disease, Achlorhydra Autoimmune Active Chronic Hepatitis, Acute Disseminated Encephalomyelitis, Acute hemorrhagic leukoencephalitis, Addison's Disease, Agammaglobulinemia, Alopecia areata, Amyotrophic Lateral Sclerosis, Ankylosing Spondylitis, Anti-GBM/TBM Nephritis, Antiphospholipid syndrome, Antisynthetase syndrome, polyarticular Arthritis, Atopic allergy, Atopic Dermatitis, Autoimmune Aplastic Anemia, Autoimmune cardiomyopathy, Autoimmune enteropathy, Autoimmune hemolytic anemia, Autoimmune hepatitis, Autoimmune inner ear disease, Autoimmune lymphoproliferative syndrome, Autoimmune peripheral neuropathy, Autoimmune pancreatitis, Autoimmune polyendocrine syndrome, Autoimmune progesterone dermatitis, Autoimmune thrombocytopenic purpura, Autoimmune uveitis, Balo disease, Balo concentric sclerosis, Bechets Syndrome, Berger's disease, Bickerstaffs encephalitis, Blau syndrome, Bullous Pemphigoid, Castleman's disease, Celiac disease, Chagas disease, Chronic Fatigue Immune Dysfunction Syndrome, Chronic recurrent multifocal osteomyelitis, Chronic lyme disease, Chronic obstructive pulmonary disease, Churg-Strauss syndrome, Cicatricial Pemphigoid, Coeliac Disease, Cogan syndrome, Cold agglutinin disease, Complement component 2 deficiency, Cranial arteritis, CREST syndrome, Crohn's Disease, Cushing's Syndrome, Cutaneous leukocytoclastic angiitis, Dego's disease, Dercum's disease, Dermatitis herpetiformis, Dermatomyositis, Diabetes mellitus type 1, Diffuse cutaneous systemic sclerosis, Dressler's syndrome, Discoid lupus erythematosus, Eczema, Endometriosis, Enthesitis-related arthritis, Eosinophilic fasciitis, Eosinophilic gastroenteritis, Epidermolysis bullosa acquisita, Erythema nodosum, Essential mixed cryoglobulinemia, Evan's syndrome, Fibrodysplasia ossificans progressiva, Fibromyalgia, Fibromyositis, Fibrosing aveolitis, Gastritis, Gastrointestinal pemphigoid, Giant cell arteritis, Glomerulonep hritis, glycogen storage diseases, Goodpasture's syndrome, Graves' disease, Guillain-Barre syndrome, Hashimoto's encephalitis, Hashimoto's thyroiditis, Haemolytic anaemia, Henoch-Schonlein purpura, Herpes gestationis, Hidradenitis suppurativa, Hirschsprung disease, Hughes syndrome, Hypogammaglobulinemia, Idiopathic pulmonary fibrosis, Idiopathic thrombocytopenic purpura, IgA nephropathy, Inclusion body myositis, Interstitial cystitis, Irritable Bowel Syndrome (IBS), Juvenile idiopathic arthritis, Juvenile rheumatoid arthritis, Kawasaki's Disease, Lambert-Eaton myasthenic syndrome, Leukocytoclastic vasculitis, Lichen planus, Lichen sclerosus, Linear IgA disease, Lou Gehrig's Disease, Lupoid hepatitis, Lupus erythematosus, Majeed syndrome, Meniere's disease, Microscopic polyangiitis, Miller-Fisher syndrome, Mixed Connective Tissue Disease, Morphea, Mowat-Wilson syndrome, Mucha-Habermann disease, Muckle-Wells syndrome, Multiple Myeloma, Myasthenia gravis, Myositis, Narcolepsy, Neuromyelitis optica, Neuromyotonia, Noonan syndrome, Occular cicatricial pemphigoid, Opsoclonus myoclonus syndrome, Ord thyroiditis, Palindromic rheumatism, Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS), Paraneoplastic cerebellar degeneration, Paroxysmal nocturnal hemoglobinuria, Parry Romberg syndrome, Parsonnage-Turner syndrome, Pars planitis, Pemphigus, Pemphigus vulgaris, Pernicious anaemia, Perivenous encephalomyelitis, POEMS syndrome, Polyarteritis nodosa, Polymyalgia rheumatica, Polymyositis, Primary biliary cirrhosis, Primary sclerosing cholangitis, Psoriasis, Psoriatic Arthritis, Pyoderma gangrenosum, Pure red cell aplasia, Rasmussen's encephalitis, Raynaud phenomenon, Relapsing polychondritis, Reiter's syndrome, Restless leg syndrome, Retroperitoneal fibrosis, Rheumatoid arthritis, Rheumatoid fever, Sarcoidosis, Schizophrenia, Schmidt syndrome, Schnitzler syndrome, Scleritis, Scleroderma, Sjögren's syndrome, Spondyloarthropathy, Sticky blood syndrome, Still's Disease, Stiff person syndrome, Subacute bacterial endocarditis (SBE), Susac's syndrome, Sweet syndrome, Sydenham Chorea, Sympathetic ophthalmia, Takayasu's arteritis, Temporal arteritis, Tolosa-Hunt syndrome, Transverse Myelitis, Ulcerative Colitis, Undifferentiated connective tissue disease, Undifferentiated spondyloarthropathy, Vasculitis, Vitiligo, Wegener's granulomatosis, Wilson's syndrome, and Wiskott-Aldrich syndrome, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of degenerative nerve diseases and disorders, namely, Alzheimer's disease, Parkinson's disease, and Huntington's disease, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of respiratory diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of endocrinological diseases and disorders, namely, growth and thyroid disorders, hypothyroidism, hypogonadism, testosterone and androgen disorders, estrogen disorders, premenstrual dysphoric disorder, premenstrual syndrome, polycystic ovary syndrome, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely, Acneiform eruptions, Autoinflammatory syndromes, Chronic blistering, Conditions of the mucous membranes, Conditions of the skin appendages, Conditions of the subcutaneous fat, Congenital anomalies, Connective tissue diseases (such as Abnormalities of dermal fibrous and elastic tissue), Dermal and subcutaneous growths, Dermatitis (including Atopic Dermatitis, Contact Dermatitis, Eczema, Pustular Dermatitis, and Seborrheic Dermatitis), Disturbances of pigmentation, Drug eruptions, Endocrine-related skin disease, Eosinophilic, Epidermal nevi, neoplasms, cysts, Erythemas, Genodermatoses, Infection-related skin disease, Lichenoid eruptions, Lymphoid-related skin disease, Monocyte- and macrophage-related skin disease, Mucinoses, Neurocutaneous, Noninfectious immunodeficiency-related skin disease, Nutrition-related skin disease, Papulosquamous hyperkeratotic (including Palmoplantar keratodermas), Pregnancy-related skin disease, Pruritic, Psoriasis, Reactive neutrophilic, Recalcitrant palmoplantar eruptions, Urticaria and angioedema, Vascular-related skin disease, bee stings, sunburn, rashes, sores, corns, calluses, alopecia, and androgenic alopecia (male pattern baldness), excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of genitourinary diseases and disorders, namely, urological diseases and disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, incontinence, prostate diseases and disorders, bladder diseases and disorders, vasomotor and menopausal symptoms, endometriosis and uterine fibroids, leiomyoma, endourology and kidney stones and gallstones, pre-eclampsia and pre-term labor, prostatitis, nephritis, cystitis, vaginitis, renal disease, polycystic ovary syndrome, erectile dysfunction, male and female sexual dysfunction disorders namely arousal disorder, pain disorder, desire disorder and orgasm disorder, amenorrhea, dysmenorrhea, and infertility, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of nephrological diseases and disorders, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of pain, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; pharmaceutical preparations for the treatment of allergies, excluding pharmaceuticals intended to treat multiple sclerosis or related diseases or conditions related to multiple sclerosis; all of the foregoing specifically excluding pharmaceutical preparations for the treatment of cancer.
Classification kind code
11
Class [042]
Pharmaceutical research and development services.
Classification kind code
11
Mark Details
Serial Number
2088866
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 22 on 06th Jun 2022 | Search Recorded |
| Submitted for opposition 20 on 06th Jun 2022 | Examiner's First Report |
| Submitted for opposition 223 on 06th Jun 2022 | Total Provisional Refusal |
| Submitted for opposition 256 on 04th Jan 2022 | Notification of Possible Opposition Sent |
| Submitted for opposition 135 on 16th Sep 2021 | Amendment to Application |
| Submitted for opposition 257 on 04th Mar 2021 | Designation Notification - Madrid Protocol |
| Submitted for opposition 1 on 03rd Mar 2021 | Created |
| Submitted for opposition 31 on 03rd Mar 2021 | Formalized |
| Submitted for opposition 30 on 05th Nov 2020 | Filed |
| Submitted for opposition 228 on 05th Nov 2020 | International Registration |